These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6650572)

  • 1. Creatine-kinase (CK) and pyruvate-kinase (PK) activities in cord blood of normal newborn infants: application to Duchenne muscular dystrophy screening programs.
    Passos MR; Zatz M
    Am J Med Genet; 1983 Nov; 16(3):367-72. PubMed ID: 6650572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD).
    Zatz M; Karp LE; Rogatko A
    Am J Med Genet; 1982 Nov; 13(3):257-62. PubMed ID: 7180871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
    Zatz M; Otto PA
    Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and environmental components of serum creatine kinase (CK) and pyruvate kinase (PK) in normal twins: implication for genetic risks estimates in Duchenne muscular dystrophy carriers.
    Rapaport D; Colletto GM; Zatz M
    Am J Med Genet; 1988 Oct; 31(2):291-8. PubMed ID: 3232697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
    Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
    Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum creatine kinase in normal newborns (author's transl)].
    Gerbaut L; Francoual C; Macart M
    Arch Fr Pediatr; 1981 Dec; 38(10):743-6. PubMed ID: 7332416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program.
    Scheuerbrandt G; Lundin A; Lövgren T; Mortier W
    Muscle Nerve; 1986 Jan; 9(1):11-23. PubMed ID: 3951477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systematic neonatal screening for Duchenne muscular dystrophy].
    Dellamonica C; Robert JM; Cotte J; Plauchu H; Dorche C
    Nouv Presse Med; 1979 Apr; 8(18):1491-3. PubMed ID: 471723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Creatine kinase activity and its isozyme levels in cord blood].
    Abe F; Nagamine Y; Ueda T; Shima K
    Rinsho Byori; 1992 Aug; 40(8):875-80. PubMed ID: 1404962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on genetic heterogeneity in Duchenne muscular dystrophy.
    Rabbi-Bortolini E; Zatz M
    Am J Med Genet; 1986 May; 24(1):111-7. PubMed ID: 3706399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of blood gas and Apgar score on cord blood cardiac troponin I.
    Türker G; Babaoğlu K; Duman C; Gökalp A; Zengin E; Arisoy AE
    J Matern Fetal Neonatal Med; 2004 Nov; 16(5):315-9. PubMed ID: 15621550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy].
    Beckmann R; Scheuerbrandt G
    Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CKBB-enzyme activity in serum in neonates born after vaginal delivery and cesarean section.
    Ezitis J; Finnström O; Hedman G; Rabow L
    Neuropediatrics; 1987 Aug; 18(3):146-8. PubMed ID: 3683752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne muscular dystrophy: comparison among different racial groups.
    Bortolini ER; Zatz M
    Am J Med Genet; 1987 Dec; 28(4):925-9. PubMed ID: 3688030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.